Substance Use Disorders: A Comprehensive Review and Update

SUNDAY, FEBRUARY 14, 2021

Buprenorphine (MAT) Waiver Training*

2:00 – 6:00 PM
THIS IS A TICKETED EVENT, NO CME CREDIT
Laura G. Kehoe, MD, MPH, FASAM

MONDAY, FEBRUARY 15, 2021

Welcome & Introduction

8:00 – 8:10 AM
David H. Rubin, MD

MODULE TOPIC 1: Etiologies of Substance Use Disorder 

Neurobiology of Addiction

8:10 – 8:30 AM
Timothy E. Wilens, MD

Genetics of Substance Use Disorders

8:30 – 8:50 AM
Robert R. Althoff, MD, PhD

Evolutionary Theories of Substance Use

8:50 – 9:10 AM
David H. Rubin, MD

MODULE TOPIC 2: General Principles and Care Delivery

Screening and Early Intervention

9:10 – 9:30 AM
Christopher Shaw, NP

Treating Addiction as a Chronic Disease

9:30 – 9:50 AM
Jessica Gray, MD

Harm Reduction

9:50 – 10:10 AM
Dinah Applewhite, MD

Break

10:10 – 10:30 AM

Emergency Room Assessment of Addiction

10:30 – 10:50 AM
Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP

The Impact of COVID on Treatment Access and Delivery

10:50 – 11:10 AM
Gene Lambert, MD, MBA

Racial & Ethnic Disparities in Substance Use Disorders

11:10 – 11:30 AM
Corrie Vilsaint, PhD

Panel Discussion

11:30 – 12:10 PM
Moderator: David H. Rubin, MD
Panelists: Christopher Shaw, NP, Dinah Applewhite, MD, Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP, Gene Lambert, MD, MBA, Corrie Vilsaint, PhD, Jessica Gray, MD

Lunch Break

12:10-1:10 PM

MODULE TOPIC 3:  Empirically Supported Psychosocial Treatment and Continuum of Care

Motivational Interviewing

1:10 – 1:30 PM
John F. Kelly, PhD

CBT

1:30 – 1:50 PM
John F. Kelly, PhD

CRAFT (Including Parents)

1:50 – 2:10 PM
Martha Kane, PhD

Family Case Discussion

2:10 – 2:30 PM
James McKowen, PhD

Panel Discussion

2:30 – 3:10 PM
Moderator: Martha Kane, PhD
Panelists: John F. Kelly, PhD, James McKowen, PhD

Break

3:10 – 3:30 PM

MODULE TOPIC 4:  Recovery Support Services  

Self-Help

3:30 – 3:50 PM
John F. Kelly, PhD

Recovery Coaching

3:50 – 4:10 PM
Martha Kane, PhD

E-Technologies

4:10 – 4:30 PM
Brandon G. Bergman, PhD

Panel Discussion

4:30 – 5:10 PM
Moderator: John F. Kelly, PhD
Panelists: Martha Kane, PhD, Brandon G. Bergman, PhD

Adjourn

5:10 PM

TUESDAY, FEBRUARY 16, 2021 

Introduction

8:00 – 8:10 AM
Timothy E. Wilens, MD

MODULE TOPIC 5: Nicotine 

Nicotine Use in Kids

8:10 – 8:30 AM
Randi Schuster, PhD

Vaping

8:30 – 8:50 AM
Randi Schuster, PhD

Nicotine and NRTs

8:50 – 9:10 AM
Shamim H. Nejad, MD, FASAM

Panel Discussion

9:10 – 9:50 AM
Moderator: Timothy E. Wilens, MD
Panelists: Randi Schuster, PhD, Shamim H. Nejad, MD, FASAM

Break

9:50-10:10 AM

MODULE TOPIC 6: Sedatives and Alcohol Use Disorders

Outpatient Management of Alcohol Use Disorder

10:10 – 10:30 AM
Laura G. Kehoe, MD, MPH, FASAM

Inpatient Management of Alcohol Withdrawal Syndromes

10:30 – 10:50 AM
Mladen Nisavic, MD

Sedatives and Hypnotics

10:50 – 11:10 AM
Robert R. Althoff, MD, PhD

Panel Discussion

11:10 – 11:50 AM
Moderator: Timothy E. Wilens, MD
Panelists: Laura G. Kehoe, MD, MPH, FASAM, Mladen Nisavic, MD,  Robert R. Althoff, MD, PhD

Lunch Break

11:50 – 12:50 PM

MODULE TOPIC 7: Stimulants

Methamphetamine

12:50 – 1:10 PM
Timothy E. Wilens, MD

Cocaine, Rx Stimulants

1:10 – 1:30 PM
Timothy E. Wilens, MD

Panel Discussion

1:30 – 2:10 PM
Moderator: Jessica Gray, MD
Panelists: Timothy E. Wilens

Break

2:10 – 2:30 PM

MODULE TOPIC 8: OPIOIDS

Overview of Opioid Use Disorder

2:30 – 2:50 PM
Sarah Wakeman, MD

Buprenorphine 101

2:50 – 3:10 PM
Laura G. Kehoe, MD, MPH, FASAM

Microdosing and Extended Release Buprenorphine

3:10 – 3:30 PM
Evan Gale, MD

Pain

3:30 – 3:50 PM
Jessica Gray, MD

Pregnancy

3:50 – 4:10 PM
Davida Schiff, MD, MSc

Panel Discussion

4:10 – 4:50 PM
Moderator: Laura G. Kehoe, MD, MPH, FASAM
Panelists: Sarah Wakeman, MD, Evan Gale, MD, Jessica Gray, MD, Davida Schiff, MD, MSc

Adjourn

4:50 PM

WEDNESDAY, FEBRUARY 17, 2021

Introduction

8:00 – 8:10 AM
David H. Rubin, MD

MODULE TOPIC 9: Marijuana

Cannabis Use & Use Disorders

8:10 – 8:30 AM
Timothy E. Wilens, MD

Clinical Management

8:30 – 8:50 AM
Robert R. Althoff, MD, PhD

Panel Discussion

8:50 – 9:30 AM
Moderator: Timothy E. Wilens, MD
Panelists: Robert R. Althoff, MD, PhD

Break

9:30 – 9:50 AM

MODULE TOPIC 10: Polysubstance Use

Fundamentals of Polysubstance Use

9:50 – 10:10 AM
Timothy E. Wilens, MD

Polysubstance Use Cases

10:10 – 10:30 AM
Laura G. Kehoe, MD, MPH, FASAM

Panel Discussion

10:30 – 11:10 AM
Moderator: David H. Rubin, MD
Panelists: Timothy E. Wilens, MD, Laura G. Kehoe, MD, MPH, FASAM

Lunch Break

11:10 – 12:10 PM

MODULE TOPIC 11: Comorbidity

ADHD

12:10 – 12:30 AM
Timothy E. Wilens, MD

Mood Disorders

12:30 – 12:50 PM
Mladen Nisavic, MD

Anxiety Disorders

12:50 – 1:10 PM
Shamim H. Nejad, MD, FASAM

Trauma

1:10 – 1:30 PM
Abigail Judge, PhD

Panel Discussion

1:30 – 2:10 PM
Moderator: Timothy E. Wilens, MD
Panelists: Shamim H. Nejad, MD, FASMA, Mladen Nisavic, MD, Abigail Judge, PhD

Break

2:10 – 2:30 PM

MODULE TOPIC 12: Hallucinogens

Hallucinogens

2:30 – 2:50 PM
Franklin King, MD

Psychedelics from Misuse to Therapeutics

2:50 – 3:10 PM
Franklin King, MD

Panel Discussion

3:10 – 3:50 PM
Moderator: David Rubin, MD
Panelists: Franklin King, MD

Adjourn

3:50 PM